Editor, Editors, USER, admin, Bureaucrats, Check users, dev, editor, founder, Interface administrators, oversight, Suppressors, Administrators, translator
10,784
edits
Line 36: | Line 36: | ||
===Vestibular and trigeminal schwannoma=== | ===Vestibular and trigeminal schwannoma=== | ||
Secondary hemifacial spasm due to vestibular schwannoma is very rare. The study by S Peker et al.<ref>S Peker, K Ozduman, T Kiliç, M N Pamir. [https://pubmed.ncbi.nlm.nih.gov/15346321/ Relief of hemifacial spasm after radiosurgery for intracanalicular vestibular schwannoma.] Minim Invasive Neurosurg. 2004 Aug;47(4):235-7. doi: 10.1055/s-2004-818485.</ref> was the first reported case of hemifacial spasm responsive to gamma knife radiosurgery in a patient with an intracanalicular vestibular schwannoma. Both spasm resolution and tumor growth control were achieved with a single session of gamma knife radiosurgery. The 49-year-old male patient with a 6-month history of right-sided hearing loss and hemifacial spasm. MRI examination revealed an intracanalicular vestibular schwannoma. The patient was treated with radiosurgery and received 13 Gy at the 50% isodose line. Control of tumor growth was achieved and there was no change in tumor volume at the latest follow-up at 22 months. The hemifacial spasm completely resolved after one year. Surgical removal of the presumably causative mass lesion has been reported to be the only treatment in secondary hemifacial spasm. <blockquote>MRI is the imaging modality of choice and is usually diagnostic in the appropriate clinical setting. The thin T2-weighted 3D CISS axial sequence is important for correct evaluation of the cisternal segment of the nerve. They are usually hypointense on T1, hyperintense on T2 with enhancement after gadolinium. But we cannot be surprised if cases like the one described by Brandon Emilio Bertot et al<ref name=":02">Brandon Emilio Bertot, Melissa Lo Presti, Katie Stormes, Jeffrey S Raskin, Andrew Jea, Daniel Chelius, Sandi Lam. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451153/#!po=12.5000 Trigeminal schwannoma presenting with malocclusion: A case report and review of the literature.]Surg Neurol Int. 2020 Aug 8;11:230. doi: 10.25259/SNI_482_2019.eCollection 2020.</ref> occur. in which a clinical case of a 16-year-old boy with an atypical incidence of a large trigeminal schwannoma presenting with painless malocclusion and unilateral masticatory weakness was presented. This case is the first documented case, to our knowledge, in which a trigeminal schwannoma generated a true malocclusion with masseter weakness and is the 19th documented case of unilateral trigeminal motor neuropathy of various etiology. From a study by Ajay Agarwal,<ref>Ajay Agarwal. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757116/ Intracranial trigeminal schwannoma] Ajay Agarwal. Neuroradiol J.2015 Feb;28(1):36-41. doi: 10.15274/NRJ-2014-10117.</ref> however, it is clear that intracranial trigeminal schwannomas are rare tumors. Patients usually present with symptoms of trigeminal nerve dysfunction, the most common symptom being facial pain. <gallery mode="slideshow" heights="200" caption="Trigeminal schwannoma presenting with malocclusion: A case report and review of the literature"> | Secondary hemifacial spasm due to vestibular schwannoma is very rare. The study by S Peker et al.<ref>S Peker, K Ozduman, T Kiliç, M N Pamir. [https://pubmed.ncbi.nlm.nih.gov/15346321/ Relief of hemifacial spasm after radiosurgery for intracanalicular vestibular schwannoma.] Minim Invasive Neurosurg. 2004 Aug;47(4):235-7. doi: 10.1055/s-2004-818485.</ref> was the first reported case of hemifacial spasm responsive to gamma knife radiosurgery in a patient with an intracanalicular vestibular schwannoma. Both spasm resolution and tumor growth control were achieved with a single session of gamma knife radiosurgery. The 49-year-old male patient with a 6-month history of right-sided hearing loss and hemifacial spasm. MRI examination revealed an intracanalicular vestibular schwannoma. The patient was treated with radiosurgery and received 13 Gy at the 50% isodose line. Control of tumor growth was achieved and there was no change in tumor volume at the latest follow-up at 22 months. The hemifacial spasm completely resolved after one year. Surgical removal of the presumably causative mass lesion has been reported to be the only treatment in secondary hemifacial spasm. <blockquote>MRI is the imaging modality of choice and is usually diagnostic in the appropriate clinical setting. The thin T2-weighted 3D CISS axial sequence is important for correct evaluation of the cisternal segment of the nerve. They are usually hypointense on T1, hyperintense on T2 with enhancement after gadolinium. But we cannot be surprised if cases like the one described by Brandon Emilio Bertot et al<ref name=":02">Brandon Emilio Bertot, Melissa Lo Presti, Katie Stormes, Jeffrey S Raskin, Andrew Jea, Daniel Chelius, Sandi Lam. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451153/#!po=12.5000 Trigeminal schwannoma presenting with malocclusion: A case report and review of the literature.]Surg Neurol Int. 2020 Aug 8;11:230. doi: 10.25259/SNI_482_2019.eCollection 2020.</ref> occur. in which a clinical case of a 16-year-old boy with an atypical incidence of a large trigeminal schwannoma presenting with painless malocclusion and unilateral masticatory weakness was presented. This case is the first documented case, to our knowledge, in which a trigeminal schwannoma generated a true malocclusion with masseter weakness and is the 19th documented case of unilateral trigeminal motor neuropathy of various etiology. From a study by Ajay Agarwal,<ref>Ajay Agarwal. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757116/ Intracranial trigeminal schwannoma] Ajay Agarwal. Neuroradiol J.2015 Feb;28(1):36-41. doi: 10.15274/NRJ-2014-10117.</ref> however, it is clear that intracranial trigeminal schwannomas are rare tumors. Patients usually present with symptoms of trigeminal nerve dysfunction, the most common symptom being facial pain. <gallery mode="slideshow" heights="200" caption="Trigeminal schwannoma presenting with malocclusion: A case report and review of the literature"> | ||
File:Scwannoma.jpeg|''' | File:Scwannoma.jpeg|'''Figure 1:''' Preoperative MRI Figure Description: T1-weighted contrast MRI with axial, sagittal, and coronal views of 5.2 × 7.8 × 5.1 cm heterogeneous extra-axial enhancing mass centered in the mesial temporal region left with involvement of the skull base and left foramen ovale, teres and spinosa, encasement and moderate narrowing of the left internal carotid artery, mild obstructive hydrocephalus and marked compression of the brainstem. | ||
File:Scwannoma 1.jpg| | File:Scwannoma 1.jpg|Figure 2: Preoperative MRI Figure Description: T1-weighted contrast MRI with axial, sagittal, and coronal views of 5.2 × 7.8 × 5.1 cm heterogeneous extra-axial enhancing mass centered in the mesial temporal region left with involvement of the skull base and left foramen ovale, teres and spinous, encasement and moderate narrowing of the left internal carotid artery, mild obstructive hydrocephalus and marked compression of the brain stem. Description of the postoperative MRI figure: T1-weighted MRI with axial, sagittal, and coronal views shows a nearly complete resection with a thin rim of residual tumor along the lateral dural margin of the left cavernous sinus/sphenoidal wing and at the end of the floor of the left middle cranial fossa extending posteriorly to the roof of the left petrous temporal bone.Preoperative MRI Figure Description: T1-weighted contrast MRI with axial, sagittal, and coronal views of 5.2 × 7.8 × 5.1 cm heterogeneous extra-axial enhancing mass centered in the mesial temporal region left with involvement of the skull base and left foramen ovale, teres and spinous, encasement and moderate narrowing of the left internal carotid artery, mild obstructive hydrocephalus and marked compression of the brain stem. Description of the postoperative MRI figure: T1-weighted MRI with axial, sagittal, and coronal views shows a nearly complete resection with a thin rim of residual tumor along the lateral dural margin of the left cavernous sinus/sphenoidal wing and at the end of the floor of the left middle cranial fossa extending posteriorly to the roof of the left petrous temporal bone. | ||
</gallery></blockquote> | </gallery></blockquote> | ||
=== | ===Multiple sclerosis and trigeminal reflexes=== | ||
We must make a further premise regarding axonal demyelination in multiple sclerosis. A study by Joanna Kamińska et el.<ref>Joanna Kamińska, Olga M Koper, Kinga Piechal, Halina Kemona . [https://pubmed.ncbi.nlm.nih.gov/28665284/ Multiple sclerosis - etiology and diagnostic potential].Postepy Hig Med Dosw. 2017 Jun 30;71(0):551-563.doi: 10.5604/01.3001.0010.3836.</ref> demonstrated that multiple sclerosis (MS) is a chronic inflammatory and demyelinating disease of autoimmune origin. The main agents responsible for the development of MS include exogenous, environmental and genetic factors. MS is characterized by multifocal and temporally scattered damage to the Central Nervous System (CNS) leading to axonal damage. Among the clinical courses of MS we can distinguish relapsing-remitting multiple sclerosis (RRMS), secondary progressive multiple sclerosis (SPSM), primary progressive multiple sclerosis (PPMS) and relapsing progressive multiple sclerosis (RPMS). Depending on the severity of the signs and symptoms, MS can be described as benign MS or malignant MS. The diagnosis of MS is based on the McDonald's diagnostic criteria, which link the clinical manifestation with the characteristic lesions demonstrated by magnetic resonance imaging (MRI); by analysis of cerebrospinal fluid (CSF) and visual evoked potentials. It should be emphasized that, despite enormous progress regarding MS and the availability of different diagnostic methods, this disease still represents a diagnostic challenge. It may result from the fact that MS has a different clinical course and lacks a single test of appropriate diagnostic sensitivity and specificity for rapid and accurate diagnosis. Precisely in reference to this last observation we must point out another significant data that emerged from a study by S K Yates and W F Brown<ref>S K Yates, W F Brown. The human jaw jerk: electrophysiologic methods to measure the latency, normal values, and changes in multiple sclerosis.Neurology. 1981 May;31(5):632-4.doi: 10.1212/wnl.31.5.632.</ref> in which we read that the jaw jerk of the masseter is present in all control subjects but commonly absent in patients with sclerosis defined multiple (SM). In some MS patients the latency was prolonged. Jaw jerk abnormalities, however, are less frequent than blink reflex responses to supraorbital nerve stimulation. However, there have been patients in whom the blink reflex was normal but the jaw jerk responses were abnormal. <blockquote>The latter observation suggests that the jaw jerk may occasionally be useful in the detection of brainstem lesions in MS.</blockquote>But at this point the doubt becomes reality: what should we think, then, of the anomalies of the trigeminal reflexes that emerged in our Mary Poppins? Could we be facing a form of 'Multiple Sclerosis? How do we distinguish the location of any demyenization whether Central or Peripheral? (Figure 3 and 4) | |||
<br /> | <br /> | ||
<center> | <center> | ||
<gallery widths="350" heights="200" perrow="2" slideshow""=""> | <gallery widths="350" heights="200" perrow="2" slideshow""=""> | ||
File:Spasmo emimasticatorio JJ.jpg|'''Figure 3:''' | File:Spasmo emimasticatorio JJ.jpg|'''Figure 3:''' Mandibular reflex detected electrophysiologically on the right (upper traces) and left (lower traces) masseters. | ||
File:Spasmo emimasticatorio SP.jpg|'''Figure 4:''' | File:Spasmo emimasticatorio SP.jpg|'''Figure 4:''' Mechanical silent period detected electrophysiologically on the right (upper overlapping traces) and left (lower overlapping traces) masseters | ||
</gallery> | </gallery> | ||
</center> | </center> | ||
=== | ===Pleomorphic adenoma=== | ||
Pleomorphic adenoma is a common benign neoplasm of the salivary glands characterized by neoplastic proliferation of epithelial (ductal) cells together with myoepithelial components, with malignant potential. It is the most common type of salivary gland tumor and the most common tumor of the parotid gland. It derives its name from architectural pleomorphism (variable appearance) seen under an optical microscope. It is also known as a "mixed tumor, salivary gland type", which refers to its dual origin from epithelial and myoepithelial elements in contrast to its pleomorphic appearance. | |||
The diagnosis of salivary gland tumors uses both tissue sampling and radiographic studies. Tissue sampling procedures include fine needle aspiration (FNA) and core needle biopsy (larger needle than FNA). Both of these procedures can be performed on an outpatient basis. Diagnostic imaging techniques for salivary gland tumors include ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). CT allows direct bilateral visualization of the salivary gland tumor and provides information on overall size and tissue invasion. CT is excellent for demonstrating bony invasion. MRI provides superior delineation of soft tissues such as perineural invasion compared to CT alone as well described by Mehmet Koyuncu et al.<ref>Mehmet Koyuncu, Teoman Seşen, Hüseyin Akan, Ahmet A Ismailoglu, Yücel Tanyeri, Atilla Tekat, Recep Unal, Lütfi Incesu. [https://pubmed.ncbi.nlm.nih.gov/14663442/ Comparison of computed tomography and magnetic resonance imaging in the diagnosis of parotid tumors].Otolaryngol Head Neck Surg. 2003 Dec;129(6):726-32.doi: 10.1016/j.otohns.2003.07.009. | |||
</ref>[[File:Cytopathology of pleomorphic adenoma.png|thumb|''' | </ref> | ||
[[File:Cytopathology of pleomorphic adenoma.png|thumb|'''Figure 5:''' Histological examination of a pleomorphic adenoma from [[wikipedia:Pleomorphic_adenoma|Wikipedia]] |alt=|center]]This last observation is very important because an invasion of the tumor of the nervous tissues in the infratemporal fossa cannot be excluded and precisely because of the complexity of the disease, we report a work by Rosalie A Machado et al.<ref>. 2017 Feb 10;8(1):86-90. | |||
doi: 10.5306/wjco.v8.i1.86. | doi: 10.5306/wjco.v8.i1.86. | ||
Rosalie A Machado, Sami P Moubayed, Azita Khorsandi, Juan C Hernandez-Prera, Mark L Urken. [https://pubmed.ncbi.nlm.nih.gov/28246588/ Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma.] World J Clin Oncol. 2017 Feb 10;8(1):86-90. doi: 10.5306/wjco.v8.i1.86. | Rosalie A Machado, Sami P Moubayed, Azita Khorsandi, Juan C Hernandez-Prera, Mark L Urken. [https://pubmed.ncbi.nlm.nih.gov/28246588/ Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma.] World J Clin Oncol. 2017 Feb 10;8(1):86-90. doi: 10.5306/wjco.v8.i1.86. | ||
</ref>, | </ref>, which can be explored in depth in the sub-chapter of Masticationpedia '[[Intermittent facial spasms as the presenting sign of a recurrent pleomorphic adenoma]]' in which the authors confirm that to date the development of facial spasms has not been reported in parotid neoplasms. The most common etiologies for hemifacial spasm are vascular compression of the facial nerve ipsilateral to the cerebellopontine angle (defined as primary or idiopathic) (62%), hereditary (2%), secondary to Bell's palsy or facial nerve injury (17 %) and imitators of hemifacial spasms (psychogenic, tics, dystonia, myoclonus, myokymia, myorrhythmia and hemimasticatory spasm) (17%). | ||
=== | ===Scleroderma=== | ||
Tiago Nardi Amaral et al. <ref>Tiago Nardi Amaral, Fernando Augusto Peres, Aline Tamires Lapa, João Francisco Marques-Neto, Simone Appenzeller. [https://pubmed.ncbi.nlm.nih.gov/23827688/ Neurologic involvement in scleroderma: a systematic review] Semin Arthritis Rheum. 2013 Dec;43(3):335-47. doi: 10.1016/ j.semarthrit. 2013.05.002. Epub 2013 Jul 1.</ref> | Tiago Nardi Amaral et al.<ref>Tiago Nardi Amaral, Fernando Augusto Peres, Aline Tamires Lapa, João Francisco Marques-Neto, Simone Appenzeller. [https://pubmed.ncbi.nlm.nih.gov/23827688/ Neurologic involvement in scleroderma: a systematic review] Semin Arthritis Rheum. 2013 Dec;43(3):335-47. doi: 10.1016/ j.semarthrit. 2013.05.002. Epub 2013 Jul 1.</ref> described the clinical characteristics, neuroimaging, and treatment of neurological involvement in systemic sclerosis (SSc) and localized scleroderma (LS) through a systematic review | ||
The authors carried out a literature search in PubMed using the following MeSH terms, scleroderma, systemic sclerosis, localized scleroderma, localized scleroderma "en coup de sabre", Parry-Romberg syndrome, cognitive impairment, memory, seizures, epilepsy, headache , depression, anxiety, mood disorders, Center for Epidemiological Studies in Depression (CES-D), SF-36, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Patient Health Questionnaire-9 (PHQ-9 ), neuropsychiatry, psychosis, neurological involvement, neuropathy, peripheral nerves, cranial nerves, carpal tunnel syndrome, ulnar entrapment, tarsal tunnel syndrome, mononeuropathy, polyneuropathy, radiculopathy, myelopathy, autonomic nervous system, nervous system, electroencephalography (EEG), electromyography (EMG), magnetic resonance imaging (MRI), and magnetic resonance angiography (MRA). Patients with other connective tissue diseases responsible for nervous system involvement were excluded from the analyses. | |||
A total of 182 case reports/studies addressing SSc and 50 reporting LS were identified. The total number of patients with SSc was 9,506, while data were available on 224 patients with LS. In LS, convulsions (41.58%) and headache (18.81%) predominated. However, descriptions of various cranial nerve involvement and hemiparesis have been made. Central Nervous System involvement in SSc was characterized by headache (23.73%), seizures (13.56%), and cognitive impairment (8.47%). Depression and anxiety were frequently observed (73.15% and 23.95%, respectively). Myopathy (51.8%), trigeminal neuropathy (16.52%), peripheral sensorimotor polyneuropathy (14.25%), and carpal tunnel syndrome (6.56%) were the most frequent peripheral nervous system involvement in SSc. Autonomic neuropathy involving the cardiovascular and gastrointestinal systems has been regularly described. The treatment of nervous system involvement, however, varied from case to case. However, in more severe cases corticosteroids and cyclophosphamide were usually prescribed.<blockquote>But this is not all because there are some variants of scleroderma such as Morphea diagnosed in our poor patient Mary Poppins who among other things did not respond positively to cortisone therapy.</blockquote> | |||
==== | ====Morphea==== | ||
Morphea is a form of scleroderma that involves isolated patches of hardened skin on the face, hands and feet, or anywhere else on the body, without involvement of internal organs. Morphea most often presents as macules or plaques a few centimeters in diameter, but can also present as bands or in guttate lesions or nodules.<ref>James, William; Berger, Timothy; Elston, Dirk (2005). ''Andrews' Diseases of the Skin: Clinical Dermatology''. (10th ed.). Saunders. Page 171. <nowiki>ISBN 0-7216-2921-0</nowiki>.</ref> Morphea is a thickening and hardening of the skin and subcutaneous tissues due to excessive collagen deposition . Morphea encompasses specific conditions ranging from very small plaques involving only the skin to widespread disease causing functional and cosmetic deformities. Morphea is distinguished from systemic sclerosis by its presumed lack of involvement of internal organs.<ref>James, William; Berger, Timothy; Elston, Dirk (2005). ''Andrews' Diseases of the Skin: Clinical Dermatology''. (10th ed.). Saunders. Page 171. <nowiki>ISBN 0-7216-2921-0</nowiki>.</ref> | |||
Unfortunately the path is still difficult because the long series of variants does not exclude a form of Morphea-induced hemimasticatory spasm as well described by H J Kim et al.<ref>H J Kim, B S Jeon, K W Lee. [https://pubmed.ncbi.nlm.nih.gov/10768634/ Hemimasticatory spasm associated with localized scleroderma and facial hemiatrophy].Arch Neurol. 2000 Apr;57(4):576-80. doi: 10.1001/archneur.57.4.576. | |||
</ref> in | </ref> in which it is asserted that on the basis of trigeminal clinical and electrophysiological findings such as the blink reflex, the jaw jerk and the masseteric silent period, focal demyelination of the motor branches of the trigeminal nerve due to deep tissue alterations is suggested as a cause of electrical activities abnormal excitatory movements resulting in involuntary chewing movement and spasm.<blockquote>The latter assertion indicates an involvement of normal and ephaptic excitatory electrical activities.</blockquote> | ||
== | ==Conclusion== | ||
Before discussing the paths implemented to reach the diagnosis of 'Hemimasticatory spasm' of our poor patient Mary Poppins, we should anticipate that the encrypted code that we were trying to identify as a communication phenomenon concerns 'ephaptic transmission', a very important and complex phenomenon to evoke but above all requires a description of the electrical transmission between neurons. | |||
Electrical signaling is a key feature of the nervous system and gives it the ability to react quickly to changes in the environment. Although synaptic communication between nerve cells is primarily perceived as chemically mediated, electrical synaptic interactions also occur. Two different strategies are responsible for electrical communication between neurons. One is the consequence of low-resistance intercellular pathways, called “gap junctions,” for the diffusion of electrical currents between the inside of two cells. The second occurs in the absence of cell-cell contacts and is a consequence of the extracellular electric fields generated by the electrical activity of neurons. In the chapter dedicated to this fundamental topic, current notions on electrical transmission will be discussed in a historical perspective, comparing the contributions of the two different forms of electrical communication to brain function. ( see [[Two Forms of Electrical Transmission Between Neurons|Two Forms of Electrical Transmission Between Neurons*)]] | |||
{{bib}} | {{bib}} |
edits